Notably, significantly higher mTOR expression was detected even in noncancerous NAA samples vs. NEA samples (Figure 1A, left and right panels), suggesting that mTOR may be a predisposing risk factor in AAs (who have higher chance to develop aggressive types of PCa). The gene discussed is MTOR; the disease is posterior cortical atrophy.